FDA removes clinical hold on Juno's cancer drug trial; shares rise

July 12 (Reuters) - Juno Therapeutics Inc said U.S.

health regulators have removed a clinical hold on its cancer

drug trial that was put in place last week following the death

of three patients,...

Read more